STAT1 and breast carcinoma: Blocking IFNAR1 and IFNAR2 in CD95 pre-treated luminal breast cancer cell lines resulted in inhibition of the CD95-induced phosphorylation of STAT1 and induction of the stemness marker SOX2 (118).